The Taiwanese biotech has launched a phase 1/2 trial to test its small molecule cancer therapy in children and young adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback